nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0434	0.06	CbGbCtD
Daunorubicin—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0375	0.0518	CbGbCtD
Daunorubicin—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0329	0.0455	CbGbCtD
Daunorubicin—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0329	0.0455	CbGbCtD
Daunorubicin—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0286	0.0395	CbGbCtD
Daunorubicin—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0278	0.0383	CbGbCtD
Daunorubicin—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0244	0.0337	CbGbCtD
Daunorubicin—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0244	0.0337	CbGbCtD
Daunorubicin—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0244	0.0337	CbGbCtD
Daunorubicin—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0244	0.0337	CbGbCtD
Daunorubicin—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0221	0.0306	CbGbCtD
Daunorubicin—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.022	0.0304	CbGbCtD
Daunorubicin—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.022	0.0304	CbGbCtD
Daunorubicin—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0211	0.0292	CbGbCtD
Daunorubicin—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0181	0.025	CbGbCtD
Daunorubicin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0178	0.0246	CbGbCtD
Daunorubicin—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0163	0.0226	CbGbCtD
Daunorubicin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0161	0.0222	CbGbCtD
Daunorubicin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0161	0.0222	CbGbCtD
Daunorubicin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0141	0.0195	CbGbCtD
Daunorubicin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0139	0.0192	CbGbCtD
Daunorubicin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0135	0.0186	CbGbCtD
Daunorubicin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0133	0.0183	CbGbCtD
Daunorubicin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0133	0.0183	CbGbCtD
Daunorubicin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0122	0.0169	CbGbCtD
Daunorubicin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0122	0.0169	CbGbCtD
Daunorubicin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.012	0.0166	CbGbCtD
Daunorubicin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0116	0.016	CbGbCtD
Daunorubicin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0105	0.0145	CbGbCtD
Daunorubicin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.01	0.0139	CbGbCtD
Daunorubicin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00908	0.0125	CbGbCtD
Daunorubicin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00905	0.0125	CbGbCtD
Daunorubicin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00878	0.0121	CbGbCtD
Daunorubicin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00794	0.011	CbGbCtD
Daunorubicin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00794	0.011	CbGbCtD
Daunorubicin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00762	0.0105	CbGbCtD
Daunorubicin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00739	0.0102	CbGbCtD
Daunorubicin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00694	0.00959	CbGbCtD
Daunorubicin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00694	0.00959	CbGbCtD
Daunorubicin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00628	0.00868	CbGbCtD
Daunorubicin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00628	0.00868	CbGbCtD
Daunorubicin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00589	0.00814	CbGbCtD
Daunorubicin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00542	0.00749	CbGbCtD
Daunorubicin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00526	0.00727	CbGbCtD
Daunorubicin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00476	0.00657	CbGbCtD
Daunorubicin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00476	0.00657	CbGbCtD
Daunorubicin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00456	0.0063	CbGbCtD
Daunorubicin—ABCC6—blood plasma—acquired immunodeficiency syndrome	0.00262	0.0403	CbGeAlD
Daunorubicin—YWHAG—blood plasma—acquired immunodeficiency syndrome	0.00247	0.0379	CbGeAlD
Daunorubicin—NR5A1—lymphoid tissue—acquired immunodeficiency syndrome	0.00145	0.0223	CbGeAlD
Daunorubicin—ABCC6—retina—acquired immunodeficiency syndrome	0.00143	0.0221	CbGeAlD
Daunorubicin—YWHAG—retina—acquired immunodeficiency syndrome	0.00135	0.0208	CbGeAlD
Daunorubicin—TOP2B—retina—acquired immunodeficiency syndrome	0.0013	0.02	CbGeAlD
Daunorubicin—NR5A1—nervous system—acquired immunodeficiency syndrome	0.00111	0.0171	CbGeAlD
Daunorubicin—NR5A1—central nervous system—acquired immunodeficiency syndrome	0.00107	0.0164	CbGeAlD
Daunorubicin—YWHAG—lymphoid tissue—acquired immunodeficiency syndrome	0.00096	0.0148	CbGeAlD
Daunorubicin—ABCC6—blood—acquired immunodeficiency syndrome	0.00096	0.0148	CbGeAlD
Daunorubicin—YWHAG—digestive system—acquired immunodeficiency syndrome	0.000948	0.0146	CbGeAlD
Daunorubicin—TOP2B—lymphoid tissue—acquired immunodeficiency syndrome	0.000925	0.0142	CbGeAlD
Daunorubicin—XDH—digestive system—acquired immunodeficiency syndrome	0.000925	0.0142	CbGeAlD
Daunorubicin—TOP2B—digestive system—acquired immunodeficiency syndrome	0.000914	0.0141	CbGeAlD
Daunorubicin—YWHAG—blood—acquired immunodeficiency syndrome	0.000903	0.0139	CbGeAlD
Daunorubicin—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000903	0.0139	CbGeAlD
Daunorubicin—YWHAG—bone marrow—acquired immunodeficiency syndrome	0.000874	0.0134	CbGeAlD
Daunorubicin—TOP2B—blood—acquired immunodeficiency syndrome	0.000871	0.0134	CbGeAlD
Daunorubicin—YWHAG—spinal cord—acquired immunodeficiency syndrome	0.00087	0.0134	CbGeAlD
Daunorubicin—NR5A1—brain—acquired immunodeficiency syndrome	0.000849	0.013	CbGeAlD
Daunorubicin—TOP2B—bone marrow—acquired immunodeficiency syndrome	0.000843	0.013	CbGeAlD
Daunorubicin—ABCC6—lung—acquired immunodeficiency syndrome	0.000841	0.0129	CbGeAlD
Daunorubicin—TOP2B—spinal cord—acquired immunodeficiency syndrome	0.000839	0.0129	CbGeAlD
Daunorubicin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000838	0.0129	CbGeAlD
Daunorubicin—YWHAG—vagina—acquired immunodeficiency syndrome	0.000837	0.0129	CbGeAlD
Daunorubicin—XDH—vagina—acquired immunodeficiency syndrome	0.000817	0.0126	CbGeAlD
Daunorubicin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000809	0.0124	CbGeAlD
Daunorubicin—TOP2B—vagina—acquired immunodeficiency syndrome	0.000807	0.0124	CbGeAlD
Daunorubicin—YWHAG—lung—acquired immunodeficiency syndrome	0.000792	0.0122	CbGeAlD
Daunorubicin—TOP2B—lung—acquired immunodeficiency syndrome	0.000763	0.0117	CbGeAlD
Daunorubicin—YWHAG—nervous system—acquired immunodeficiency syndrome	0.000733	0.0113	CbGeAlD
Daunorubicin—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.000725	0.0111	CbGeAlD
Daunorubicin—TOP2B—nervous system—acquired immunodeficiency syndrome	0.000707	0.0109	CbGeAlD
Daunorubicin—YWHAG—central nervous system—acquired immunodeficiency syndrome	0.000706	0.0109	CbGeAlD
Daunorubicin—TOP2A—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.000697	0.271	CbGdCrCtD
Daunorubicin—POR—blood—acquired immunodeficiency syndrome	0.000687	0.0106	CbGeAlD
Daunorubicin—TOP2B—central nervous system—acquired immunodeficiency syndrome	0.000681	0.0105	CbGeAlD
Daunorubicin—POR—bone marrow—acquired immunodeficiency syndrome	0.000665	0.0102	CbGeAlD
Daunorubicin—POR—spinal cord—acquired immunodeficiency syndrome	0.000662	0.0102	CbGeAlD
Daunorubicin—TOP2A—blood—acquired immunodeficiency syndrome	0.00064	0.00984	CbGeAlD
Daunorubicin—TOP2A—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.000638	0.248	CbGdCrCtD
Daunorubicin—TOP2A—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.000638	0.248	CbGdCrCtD
Daunorubicin—POR—vagina—acquired immunodeficiency syndrome	0.000637	0.00979	CbGeAlD
Daunorubicin—TOP2A—bone marrow—acquired immunodeficiency syndrome	0.00062	0.00952	CbGeAlD
Daunorubicin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000607	0.00933	CbGeAlD
Daunorubicin—POR—lung—acquired immunodeficiency syndrome	0.000602	0.00926	CbGeAlD
Daunorubicin—TOP2A—vagina—acquired immunodeficiency syndrome	0.000593	0.00912	CbGeAlD
Daunorubicin—ABCC10—lymphoid tissue—acquired immunodeficiency syndrome	0.000579	0.0089	CbGeAlD
Daunorubicin—ABCC10—digestive system—acquired immunodeficiency syndrome	0.000572	0.0088	CbGeAlD
Daunorubicin—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000562	0.00865	CbGeAlD
Daunorubicin—TOP2A—lung—acquired immunodeficiency syndrome	0.000561	0.00863	CbGeAlD
Daunorubicin—YWHAG—brain—acquired immunodeficiency syndrome	0.000561	0.00862	CbGeAlD
Daunorubicin—ABCC10—blood—acquired immunodeficiency syndrome	0.000545	0.00838	CbGeAlD
Daunorubicin—YWHAG—lymph node—acquired immunodeficiency syndrome	0.000542	0.00833	CbGeAlD
Daunorubicin—TOP2B—brain—acquired immunodeficiency syndrome	0.00054	0.00831	CbGeAlD
Daunorubicin—ABCC10—bone marrow—acquired immunodeficiency syndrome	0.000527	0.00811	CbGeAlD
Daunorubicin—ABCC10—spinal cord—acquired immunodeficiency syndrome	0.000525	0.00807	CbGeAlD
Daunorubicin—TOP2B—lymph node—acquired immunodeficiency syndrome	0.000522	0.00803	CbGeAlD
Daunorubicin—ABCC10—vagina—acquired immunodeficiency syndrome	0.000505	0.00777	CbGeAlD
Daunorubicin—ABCC10—lung—acquired immunodeficiency syndrome	0.000478	0.00735	CbGeAlD
Daunorubicin—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000459	0.00706	CbGeAlD
Daunorubicin—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000455	0.007	CbGeAlD
Daunorubicin—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.00045	0.00692	CbGeAlD
Daunorubicin—ABCC2—blood—acquired immunodeficiency syndrome	0.000438	0.00673	CbGeAlD
Daunorubicin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00043	0.0066	CbGeAlD
Daunorubicin—CYP1B1—blood—acquired immunodeficiency syndrome	0.000429	0.00659	CbGeAlD
Daunorubicin—POR—brain—acquired immunodeficiency syndrome	0.000426	0.00655	CbGeAlD
Daunorubicin—POR—lymph node—acquired immunodeficiency syndrome	0.000412	0.00633	CbGeAlD
Daunorubicin—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000398	0.00611	CbGeAlD
Daunorubicin—ABCC1—blood—acquired immunodeficiency syndrome	0.000386	0.00593	CbGeAlD
Daunorubicin—TOP2A—lymph node—acquired immunodeficiency syndrome	0.000384	0.0059	CbGeAlD
Daunorubicin—CYP1B1—lung—acquired immunodeficiency syndrome	0.000376	0.00578	CbGeAlD
Daunorubicin—ABCC1—vagina—acquired immunodeficiency syndrome	0.000357	0.00549	CbGeAlD
Daunorubicin—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000348	0.00535	CbGeAlD
Daunorubicin—ABCC10—brain—acquired immunodeficiency syndrome	0.000338	0.0052	CbGeAlD
Daunorubicin—ABCC1—lung—acquired immunodeficiency syndrome	0.000338	0.0052	CbGeAlD
Daunorubicin—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000335	0.00515	CbGeAlD
Daunorubicin—ABCC10—lymph node—acquired immunodeficiency syndrome	0.000327	0.00502	CbGeAlD
Daunorubicin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000322	0.00496	CbGeAlD
Daunorubicin—ABCG2—blood—acquired immunodeficiency syndrome	0.000319	0.00491	CbGeAlD
Daunorubicin—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000318	0.00489	CbGeAlD
Daunorubicin—TOP2A—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.000314	0.122	CbGdCrCtD
Daunorubicin—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000311	0.00478	CbGeAlD
Daunorubicin—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000309	0.00475	CbGeAlD
Daunorubicin—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000307	0.00473	CbGeAlD
Daunorubicin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000307	0.00472	CbGeAlD
Daunorubicin—CYP1A1—blood—acquired immunodeficiency syndrome	0.000303	0.00466	CbGeAlD
Daunorubicin—CYP3A5—blood—acquired immunodeficiency syndrome	0.000296	0.00455	CbGeAlD
Daunorubicin—ABCG2—vagina—acquired immunodeficiency syndrome	0.000296	0.00455	CbGeAlD
Daunorubicin—TOP2A—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.112	CbGdCrCtD
Daunorubicin—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000281	0.00432	CbGeAlD
Daunorubicin—ABCG2—lung—acquired immunodeficiency syndrome	0.00028	0.0043	CbGeAlD
Daunorubicin—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000275	0.00422	CbGeAlD
Daunorubicin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000269	0.00414	CbGeAlD
Daunorubicin—CYP1B1—brain—acquired immunodeficiency syndrome	0.000266	0.00409	CbGeAlD
Daunorubicin—CYP1A1—lung—acquired immunodeficiency syndrome	0.000266	0.00408	CbGeAlD
Daunorubicin—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000262	0.00403	CbGeAlD
Daunorubicin—CYP3A5—lung—acquired immunodeficiency syndrome	0.00026	0.00399	CbGeAlD
Daunorubicin—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000257	0.00395	CbGeAlD
Daunorubicin—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000246	0.00378	CbGeAlD
Daunorubicin—ABCC1—brain—acquired immunodeficiency syndrome	0.000239	0.00368	CbGeAlD
Daunorubicin—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000237	0.00364	CbGeAlD
Daunorubicin—ABCB1—retina—acquired immunodeficiency syndrome	0.000235	0.00362	CbGeAlD
Daunorubicin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000233	0.00359	CbGeAlD
Daunorubicin—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000231	0.00355	CbGeAlD
Daunorubicin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000222	0.00342	CbGeAlD
Daunorubicin—ABCG2—brain—acquired immunodeficiency syndrome	0.000198	0.00304	CbGeAlD
Daunorubicin—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000191	0.00294	CbGeAlD
Daunorubicin—CYP1A1—brain—acquired immunodeficiency syndrome	0.000188	0.00289	CbGeAlD
Daunorubicin—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000182	0.00279	CbGeAlD
Daunorubicin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00018	0.00277	CbGeAlD
Daunorubicin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000174	0.00267	CbGeAlD
Daunorubicin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000167	0.00257	CbGeAlD
Daunorubicin—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000165	0.00254	CbGeAlD
Daunorubicin—ABCB1—blood—acquired immunodeficiency syndrome	0.000157	0.00242	CbGeAlD
Daunorubicin—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000152	0.00234	CbGeAlD
Daunorubicin—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000152	0.00233	CbGeAlD
Daunorubicin—ABCB1—vagina—acquired immunodeficiency syndrome	0.000146	0.00224	CbGeAlD
Daunorubicin—ABCB1—lung—acquired immunodeficiency syndrome	0.000138	0.00212	CbGeAlD
Daunorubicin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000136	0.000652	CcSEcCtD
Daunorubicin—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000649	CcSEcCtD
Daunorubicin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000135	0.000648	CcSEcCtD
Daunorubicin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000647	CcSEcCtD
Daunorubicin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.000646	CcSEcCtD
Daunorubicin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000646	CcSEcCtD
Daunorubicin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000645	CcSEcCtD
Daunorubicin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000645	CcSEcCtD
Daunorubicin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000134	0.000644	CcSEcCtD
Daunorubicin—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000644	CcSEcCtD
Daunorubicin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000643	CcSEcCtD
Daunorubicin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000643	CcSEcCtD
Daunorubicin—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000642	CcSEcCtD
Daunorubicin—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000642	CcSEcCtD
Daunorubicin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000641	CcSEcCtD
Daunorubicin—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00064	CcSEcCtD
Daunorubicin—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00064	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000638	CcSEcCtD
Daunorubicin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.000637	CcSEcCtD
Daunorubicin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.000636	CcSEcCtD
Daunorubicin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000132	0.000635	CcSEcCtD
Daunorubicin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000132	0.000635	CcSEcCtD
Daunorubicin—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000634	CcSEcCtD
Daunorubicin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000633	CcSEcCtD
Daunorubicin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000633	CcSEcCtD
Daunorubicin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000633	CcSEcCtD
Daunorubicin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000633	CcSEcCtD
Daunorubicin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000631	CcSEcCtD
Daunorubicin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000631	CcSEcCtD
Daunorubicin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000631	CcSEcCtD
Daunorubicin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000629	CcSEcCtD
Daunorubicin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00013	0.000626	CcSEcCtD
Daunorubicin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000626	CcSEcCtD
Daunorubicin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000626	CcSEcCtD
Daunorubicin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000625	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000625	CcSEcCtD
Daunorubicin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000625	CcSEcCtD
Daunorubicin—Pain—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000621	CcSEcCtD
Daunorubicin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000621	CcSEcCtD
Daunorubicin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.00062	CcSEcCtD
Daunorubicin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.00062	CcSEcCtD
Daunorubicin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00062	CcSEcCtD
Daunorubicin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000619	CcSEcCtD
Daunorubicin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000618	CcSEcCtD
Daunorubicin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000617	CcSEcCtD
Daunorubicin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000617	CcSEcCtD
Daunorubicin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000128	0.000616	CcSEcCtD
Daunorubicin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000616	CcSEcCtD
Daunorubicin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000128	0.000614	CcSEcCtD
Daunorubicin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000128	0.000614	CcSEcCtD
Daunorubicin—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000128	0.00196	CbGeAlD
Daunorubicin—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000612	CcSEcCtD
Daunorubicin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000612	CcSEcCtD
Daunorubicin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000611	CcSEcCtD
Daunorubicin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000611	CcSEcCtD
Daunorubicin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.00061	CcSEcCtD
Daunorubicin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000609	CcSEcCtD
Daunorubicin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000609	CcSEcCtD
Daunorubicin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000609	CcSEcCtD
Daunorubicin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000607	CcSEcCtD
Daunorubicin—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000607	CcSEcCtD
Daunorubicin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000605	CcSEcCtD
Daunorubicin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000602	CcSEcCtD
Daunorubicin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.0006	CcSEcCtD
Daunorubicin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000598	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000598	CcSEcCtD
Daunorubicin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000597	CcSEcCtD
Daunorubicin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000596	CcSEcCtD
Daunorubicin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000596	CcSEcCtD
Daunorubicin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000596	CcSEcCtD
Daunorubicin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000124	0.000596	CcSEcCtD
Daunorubicin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000594	CcSEcCtD
Daunorubicin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000124	0.000594	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000594	CcSEcCtD
Daunorubicin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000594	CcSEcCtD
Daunorubicin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000592	CcSEcCtD
Daunorubicin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000592	CcSEcCtD
Daunorubicin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000123	0.000591	CcSEcCtD
Daunorubicin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000591	CcSEcCtD
Daunorubicin—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000123	0.00189	CbGeAlD
Daunorubicin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000589	CcSEcCtD
Daunorubicin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000587	CcSEcCtD
Daunorubicin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000587	CcSEcCtD
Daunorubicin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000587	CcSEcCtD
Daunorubicin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.000586	CcSEcCtD
Daunorubicin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.000586	CcSEcCtD
Daunorubicin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000585	CcSEcCtD
Daunorubicin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000122	0.000585	CcSEcCtD
Daunorubicin—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000584	CcSEcCtD
Daunorubicin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000583	CcSEcCtD
Daunorubicin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000121	0.000583	CcSEcCtD
Daunorubicin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000581	CcSEcCtD
Daunorubicin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000581	CcSEcCtD
Daunorubicin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000581	CcSEcCtD
Daunorubicin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.00058	CcSEcCtD
Daunorubicin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000579	CcSEcCtD
Daunorubicin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000578	CcSEcCtD
Daunorubicin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000577	CcSEcCtD
Daunorubicin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000575	CcSEcCtD
Daunorubicin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000574	CcSEcCtD
Daunorubicin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000574	CcSEcCtD
Daunorubicin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000574	CcSEcCtD
Daunorubicin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000119	0.000573	CcSEcCtD
Daunorubicin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000572	CcSEcCtD
Daunorubicin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000119	0.000571	CcSEcCtD
Daunorubicin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.00057	CcSEcCtD
Daunorubicin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000568	CcSEcCtD
Daunorubicin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000568	CcSEcCtD
Daunorubicin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000567	CcSEcCtD
Daunorubicin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000118	0.000566	CcSEcCtD
Daunorubicin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000566	CcSEcCtD
Daunorubicin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000118	0.000566	CcSEcCtD
Daunorubicin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000565	CcSEcCtD
Daunorubicin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000565	CcSEcCtD
Daunorubicin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000564	CcSEcCtD
Daunorubicin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000117	0.000563	CcSEcCtD
Daunorubicin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000562	CcSEcCtD
Daunorubicin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000562	CcSEcCtD
Daunorubicin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000561	CcSEcCtD
Daunorubicin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000561	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000561	CcSEcCtD
Daunorubicin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.00056	CcSEcCtD
Daunorubicin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000558	CcSEcCtD
Daunorubicin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000557	CcSEcCtD
Daunorubicin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000557	CcSEcCtD
Daunorubicin—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000557	CcSEcCtD
Daunorubicin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000557	CcSEcCtD
Daunorubicin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000554	CcSEcCtD
Daunorubicin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000554	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000553	CcSEcCtD
Daunorubicin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000115	0.000552	CcSEcCtD
Daunorubicin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000552	CcSEcCtD
Daunorubicin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000549	CcSEcCtD
Daunorubicin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000548	CcSEcCtD
Daunorubicin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000546	CcSEcCtD
Daunorubicin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000545	CcSEcCtD
Daunorubicin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000542	CcSEcCtD
Daunorubicin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000542	CcSEcCtD
Daunorubicin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000541	CcSEcCtD
Daunorubicin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000541	CcSEcCtD
Daunorubicin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000539	CcSEcCtD
Daunorubicin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000539	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000537	CcSEcCtD
Daunorubicin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000112	0.000535	CcSEcCtD
Daunorubicin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000535	CcSEcCtD
Daunorubicin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000534	CcSEcCtD
Daunorubicin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000111	0.000533	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000532	CcSEcCtD
Daunorubicin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000531	CcSEcCtD
Daunorubicin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000528	CcSEcCtD
Daunorubicin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000528	CcSEcCtD
Daunorubicin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00011	0.000525	CcSEcCtD
Daunorubicin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000523	CcSEcCtD
Daunorubicin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000521	CcSEcCtD
Daunorubicin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000521	CcSEcCtD
Daunorubicin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000521	CcSEcCtD
Daunorubicin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000519	CcSEcCtD
Daunorubicin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000519	CcSEcCtD
Daunorubicin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000519	CcSEcCtD
Daunorubicin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000519	CcSEcCtD
Daunorubicin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000519	CcSEcCtD
Daunorubicin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000108	0.000516	CcSEcCtD
Daunorubicin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000514	CcSEcCtD
Daunorubicin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000508	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000508	CcSEcCtD
Daunorubicin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000505	CcSEcCtD
Daunorubicin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000504	CcSEcCtD
Daunorubicin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000504	CcSEcCtD
Daunorubicin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.0005	CcSEcCtD
Daunorubicin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000499	CcSEcCtD
Daunorubicin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000499	CcSEcCtD
Daunorubicin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000497	CcSEcCtD
Daunorubicin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000497	CcSEcCtD
Daunorubicin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000496	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000496	CcSEcCtD
Daunorubicin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000495	CcSEcCtD
Daunorubicin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000492	CcSEcCtD
Daunorubicin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000492	CcSEcCtD
Daunorubicin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000492	CcSEcCtD
Daunorubicin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000489	CcSEcCtD
Daunorubicin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000485	CcSEcCtD
Daunorubicin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000484	CcSEcCtD
Daunorubicin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000483	CcSEcCtD
Daunorubicin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000482	CcSEcCtD
Daunorubicin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000481	CcSEcCtD
Daunorubicin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.00048	CcSEcCtD
Daunorubicin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.0001	0.00048	CcSEcCtD
Daunorubicin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.00048	CcSEcCtD
Daunorubicin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.00048	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.96e-05	0.000478	CcSEcCtD
Daunorubicin—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000476	CcSEcCtD
Daunorubicin—Pain—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000476	CcSEcCtD
Daunorubicin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.81e-05	0.000471	CcSEcCtD
Daunorubicin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.78e-05	0.000469	CcSEcCtD
Daunorubicin—ABCB1—brain—acquired immunodeficiency syndrome	9.77e-05	0.0015	CbGeAlD
Daunorubicin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.68e-05	0.000464	CcSEcCtD
Daunorubicin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000464	CcSEcCtD
Daunorubicin—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.66e-05	0.000464	CcSEcCtD
Daunorubicin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000462	CcSEcCtD
Daunorubicin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000462	CcSEcCtD
Daunorubicin—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.62e-05	0.000462	CcSEcCtD
Daunorubicin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.57e-05	0.000459	CcSEcCtD
Daunorubicin—Rash—Indinavir—acquired immunodeficiency syndrome	9.54e-05	0.000458	CcSEcCtD
Daunorubicin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.53e-05	0.000457	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.5e-05	0.000456	CcSEcCtD
Daunorubicin—Headache—Indinavir—acquired immunodeficiency syndrome	9.48e-05	0.000455	CcSEcCtD
Daunorubicin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.45e-05	0.000454	CcSEcCtD
Daunorubicin—ABCB1—lymph node—acquired immunodeficiency syndrome	9.44e-05	0.00145	CbGeAlD
Daunorubicin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.36e-05	0.000449	CcSEcCtD
Daunorubicin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.000447	CcSEcCtD
Daunorubicin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000443	CcSEcCtD
Daunorubicin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.18e-05	0.00044	CcSEcCtD
Daunorubicin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.18e-05	0.00044	CcSEcCtD
Daunorubicin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.09e-05	0.000436	CcSEcCtD
Daunorubicin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.08e-05	0.000435	CcSEcCtD
Daunorubicin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.05e-05	0.000434	CcSEcCtD
Daunorubicin—Rash—Efavirenz—acquired immunodeficiency syndrome	9.01e-05	0.000432	CcSEcCtD
Daunorubicin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.01e-05	0.000432	CcSEcCtD
Daunorubicin—Nausea—Indinavir—acquired immunodeficiency syndrome	8.99e-05	0.000431	CcSEcCtD
Daunorubicin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.00043	CcSEcCtD
Daunorubicin—Headache—Efavirenz—acquired immunodeficiency syndrome	8.96e-05	0.00043	CcSEcCtD
Daunorubicin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.95e-05	0.000429	CcSEcCtD
Daunorubicin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.73e-05	0.000419	CcSEcCtD
Daunorubicin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.7e-05	0.000417	CcSEcCtD
Daunorubicin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.65e-05	0.000415	CcSEcCtD
Daunorubicin—Rash—Delavirdine—acquired immunodeficiency syndrome	8.62e-05	0.000414	CcSEcCtD
Daunorubicin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.62e-05	0.000413	CcSEcCtD
Daunorubicin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.61e-05	0.000413	CcSEcCtD
Daunorubicin—Headache—Delavirdine—acquired immunodeficiency syndrome	8.57e-05	0.000411	CcSEcCtD
Daunorubicin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.000411	CcSEcCtD
Daunorubicin—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.49e-05	0.000407	CcSEcCtD
Daunorubicin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.36e-05	0.000401	CcSEcCtD
Daunorubicin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.33e-05	0.0004	CcSEcCtD
Daunorubicin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.33e-05	0.0004	CcSEcCtD
Daunorubicin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.22e-05	0.000394	CcSEcCtD
Daunorubicin—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.12e-05	0.00039	CcSEcCtD
Daunorubicin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000386	CcSEcCtD
Daunorubicin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000386	CcSEcCtD
Daunorubicin—Rash—Ritonavir—acquired immunodeficiency syndrome	7.98e-05	0.000383	CcSEcCtD
Daunorubicin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.97e-05	0.000382	CcSEcCtD
Daunorubicin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.95e-05	0.000381	CcSEcCtD
Daunorubicin—Headache—Ritonavir—acquired immunodeficiency syndrome	7.92e-05	0.00038	CcSEcCtD
Daunorubicin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.74e-05	0.000371	CcSEcCtD
Daunorubicin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000368	CcSEcCtD
Daunorubicin—Rash—Saquinavir—acquired immunodeficiency syndrome	7.68e-05	0.000368	CcSEcCtD
Daunorubicin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.67e-05	0.000368	CcSEcCtD
Daunorubicin—Headache—Saquinavir—acquired immunodeficiency syndrome	7.63e-05	0.000366	CcSEcCtD
Daunorubicin—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.51e-05	0.00036	CcSEcCtD
Daunorubicin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000354	CcSEcCtD
Daunorubicin—Rash—Lamivudine—acquired immunodeficiency syndrome	7.32e-05	0.000351	CcSEcCtD
Daunorubicin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.32e-05	0.000351	CcSEcCtD
Daunorubicin—Headache—Lamivudine—acquired immunodeficiency syndrome	7.28e-05	0.000349	CcSEcCtD
Daunorubicin—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.23e-05	0.000347	CcSEcCtD
Daunorubicin—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.9e-05	0.000331	CcSEcCtD
